ロード中...

Hope and Disappointment: Covalent Inhibitors to Overcome Drug Resistance in Non-Small Cell Lung Cancer

In the last five years, the detailed understanding of how to overcome T790M drug resistance in non-small cell lung cancer (NSCLC) has culminated in the development of a third-generation of covalent EGFR inhibitors with excellent clinical outcomes. However, the emergence of a newly discovered acquire...

詳細記述

保存先:
書誌詳細
出版年:ACS Med Chem Lett
主要な著者: Engel, Julian, Lategahn, Jonas, Rauh, Daniel
フォーマット: Artigo
言語:Inglês
出版事項: American Chemical Society 2015
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716607/
https://ncbi.nlm.nih.gov/pubmed/26819655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.5b00475
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!